Showing results (51-60 of 201) with videos related to

Sort By:
Pageof 21
Blood Cancer Discovery|January 11, 2022
Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell TherapyKevin O McNerney, Amanda M DiNofia, David T Teachey, et al.
The Journal of Allergy and Clinical Immunology|November 17, 2023
Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disordersAude Magerus, Anne Rensing-Ehl, V Koneti Rao, et al.
Immunologic Research|August 22, 2008
Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative diseaseValerie I Brown, Alix E Seif, Gregor S D Reid, et al.
British Journal of Haematology|May 23, 2013
Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimensDeepakBabu Chellapandian, Rupali Das, Kristin Zelley, et al.
Best Practice & Research. Clinical Haematology|March 12, 2023
Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphomaYaya Chu, Aliza Gardenswartz, Caroline Diorio, et al.
Cytotherapy|May 17, 2017
Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell functionNathan Singh, Ted J Hofmann, Zachary Gershenson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 25, 2021
Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon responseElizabeth Y Li, Jason Xu, Nya D Nelson, et al.
Trends in Cancer|December 23, 2025
HSPC-like blasts in acute lymphoblastic leukemia: biology and therapeutic opportunitiesJason Xu, Vanessa A Kennedy, Connie Ma, et al.
Pageof 21